In patients treated with semaglutide, median duration of nausea was 8 days, vomiting 2 days, diarrhoea 3 days, and constipation 47 days. Over the 68-week trial period nausea occurred in 43.9% of patients (16.1% placebo)
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes
The two peptides Ipamorelin and CJC-1295 are often considered by individuals seeking potential benefits related to growth hormone (GH) release
Costs vary widely based on insurance, diagnosis, pharmacy, location, manufacturer programs, and whether the medication is being prescribed for diabetes or weight management
Upon binding cytoplasmic DNA, it recruits RIP2 via its WD40 domain, activating NF-B-mediated inflammation